8/16/24 08:01 | 8/15/24 | IMNN | Imunon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | Exec CB | P | 26 | 1.03 | 0 | 25 | 8 | 353 | D | | | | | | | | | | | | | | |
4/12/22 14:19 | 4/12/22 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 14 | 3.53 | 0 | 4 | 32 | 17 | D | | | | | | | | | | | | | | |
5/16/19 15:50 | 5/16/19 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 11 | 2.16 | 0 | 5 | 18 | 33 | D | | | | | | | | | | | | | | |
10/30/18 08:38 | 10/29/18 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 15 | 2.06 | 0 | 8 | 37 | 28 | D | | | | | | | | | | | | | | |
4/9/18 13:14 | 4/9/18 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 6 | 2.30 | 0 | 3 | 14 | 20 | D | | | | | | | | | | | | | | |
3/5/18 11:24 | 3/5/18 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 18 | 2.38 | 0 | 8 | 74 | 18 | D | | | | | | | | | | | | | | |
10/11/16 09:13 | 10/7/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 11 | 1.14 | 0 | 10 | 8 | 143 | D | -56 | -36 | -17 | -7 | -4 | -8 | -3 | -3 | -2 | -7 | -24 | -74 | -75 | |
8/17/16 09:11 | 8/16/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 6 | 1.25 | 0 | 5 | 4 | 133 | D | -60 | -43 | -4 | -16 | -6 | -2 | 2 | 1 | 0 | 6 | -2 | -32 | -82 | |
6/16/16 16:52 | 6/16/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CB,P,CEO | P | 10 | 1.35 | 0 | 8 | 6 | 128 | D | -61 | -43 | -25 | 2 | -11 | -14 | -4 | -4 | -5 | -5 | -7 | -8 | -53 | |
2/19/16 16:19 | 2/19/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CEO | P | 4 | 1.27 | 0 | 3 | 3 | 121 | D | -66 | -55 | -42 | -30 | -29 | -6 | 13 | 16 | 4 | -4 | 19 | 17 | -1 | -82 |
2/17/16 12:50 | 2/17/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CEO | P | 3 | 1.27 | 0 | 2 | 2 | 118 | D | -68 | -50 | -46 | -34 | -37 | -12 | -7 | 10 | 7 | 4 | 9 | 23 | 3 | -73 |
2/16/16 16:50 | 2/16/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CEO | P | 5 | 1.20 | 0 | 5 | 4 | 116 | D | -70 | -53 | -52 | -42 | -43 | -22 | -16 | -4 | 8 | 9 | 18 | 26 | -1 | -75 |
2/12/16 16:31 | 2/12/16 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CEO | P | 7 | 1.13 | 0 | 7 | 6 | 111 | D | -70 | -54 | -51 | -43 | -43 | -22 | -19 | -4 | 11 | 16 | 30 | 33 | 14 | -59 |
8/11/15 16:03 | 8/10/15 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | CEO | P | 11 | 2.29 | 1 | 5 | 7 | 80 | D | -60 | -30 | -4 | -11 | -4 | -8 | -4 | 2 | -2 | -3 | -6 | -17 | -50 | -44 |
8/15/14 12:33 | 8/15/14 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P.a | 12 | 3.12 | 1 | 4 | 6 | 75 | D | -77 | -41 | -14 | 3 | -4 | -6 | -2 | -2 | -3 | -2 | -4 | -22 | -25 | -30 |
8/15/14 11:58 | 8/15/14 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P | 12 | 3.12 | 1 | 4 | 6 | 67 | D | -77 | -41 | -14 | 3 | -4 | -6 | -2 | -2 | -3 | -2 | -4 | -22 | -25 | -30 |
6/11/14 13:35 | 6/11/14 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P | 16 | 3.20 | 0 | 5 | 9 | 63 | D | -68 | -58 | -18 | -19 | -4 | 2 | -2 | 3 | 1 | 11 | -3 | 3 | -24 | -21 |
3/14/14 11:14 | 3/14/14 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | DO | P,CEO | P | 15 | 3.84 | 2 | 4 | 7 | 58 | D | -50 | -21 | -33 | 1 | 2 | 6 | 0 | -4 | 2 | -2 | -19 | -16 | -16 | -31 |
11/19/13 10:35 | 11/19/13 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | P,CEO | P | 10 | 3.59 | 2 | 3 | 6 | 54 | D | -74 | -85 | -14 | -25 | -34 | -29 | -10 | -5 | -1 | -3 | 3 | -1 | -14 | -31 |
8/16/13 13:29 | 8/16/13 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P | 5 | 1.08 | 1 | 5 | 2 | 228 | D | -60 | -64 | -11 | 24 | 2 | -3 | -9 | -6 | -6 | 0 | 8 | -27 | -29 | -41 |
6/12/13 10:25 | 6/12/13 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P | 13 | 1.35 | 4 | 10 | 5 | 223 | D | -50 | -30 | -78 | 49 | 89 | 69 | -6 | -10 | -10 | -18 | -29 | -20 | -48 | -56 |
12/7/12 10:55 | 12/7/12 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | P,CEO | M.d | 48 | 2.77 | 2 | 17 | 9 | 213 | D | 173 | 236 | 242 | 69 | 70 | 42 | -2 | -4 | -1 | 19 | 6 | -85 | -78 | -89 |
9/14/12 14:43 | 9/14/12 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P | 25 | 5.03 | 1 | 5 | 3 | 196 | D | 60 | 54 | 189 | 132 | 67 | 11 | 13 | 1 | 3 | 16 | 1 | 70 | -79 | -76 |
12/7/11 09:14 | 12/5/11 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | NJ | O | CEO | P | 11 | 2.18 | 0 | 5 | 3 | 166 | D | -30 | -25 | -36 | -43 | -26 | -35 | -28 | -4 | 0 | -3 | -5 | -13 | 11 | 263 |
5/31/11 13:12 | 5/26/11 | CLSN | Celsion Corp | DE | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | MD | O | CEO | P.d | 48 | 2.77 | 0 | 17 | 12 | 161 | D | -24 | -18 | 12 | 23 | 38 | 12 | 13 | 7 | 1 | 1 | -1 | 5 | -8 | -35 |
5/7/10 11:08 | 5/7/10 | CLSN | Celsion Corp | MD | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | MD | O | P,CEO | P | 16 | 3.95 | 0 | 4 | 3 | 127 | D | -4 | 23 | 31 | 43 | -11 | -26 | -22 | -21 | 0 | 15 | -15 | -15 | -21 | -30 |
4/30/10 13:20 | 1/19/08 | CLSN | Celsion Corp | MD | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | MD | O | CEO | M.d | 0 | 0.00 | 0 | 33 | 37 | 123 | D | 4 | 55 | 49 | 72 | 18 | 13 | -3 | -3 | 2 | -20 | -26 | -33 | -39 | -41 |
4/15/10 17:05 | 1/19/10 | CLSN | Celsion Corp | MD | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | MD | O | CEO | M.d | 0 | 0.00 | 0 | 17 | 17 | 114 | D | -2 | 45 | 47 | 65 | 56 | 12 | 17 | 13 | 5 | -1 | -12 | -41 | -31 | -57 |
11/19/09 13:59 | 11/19/09 | CLSN | Celsion Corp | MD | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | MD | DO | P,CEO | P | 19 | 3.21 | 0 | 6 | 9 | 72 | D | -35 | 20 | -24 | -4 | -6 | 0 | 2 | 0 | -4 | -6 | -14 | -6 | 21 | -9 |
8/17/09 14:11 | 8/17/09 | CLSN | Celsion Corp | MD | Health | Drug | Pharmaceutical Preparations | Tardugno Michael H | MD | DO | P,CEO | P | 17 | 3.30 | 0 | 5 | 8 | 66 | | | | | | | | | | 2 | 8 | 33 | 2 | -14 | 0 |
3/18/09 09:08 | 3/17/09 | CLSN | Celsion Corp | MD | Health | ElcMd | Electromedical & Electrothera | Tardugno Michael H | MD | DO | P,CEO | P | 10 | 2.56 | 0 | 4 | 7 | 61 | | | | | | | | | | 1 | 14 | 18 | 78 | 72 | 51 |
11/17/08 17:08 | 11/14/08 | CLSN | Celsion Corp | MD | Health | ElcMd | Electromedical & Electrothera | Tardugno Michael H | MD | DO | P,CEO | P | 9 | 2.83 | 0 | 3 | 10 | 32 | D | 7 | -49 | -39 | -32 | 4 | -9 | -12 | -12 | -4 | -30 | -3 | -24 | 42 | 18 |
6/18/08 09:06 | 6/16/08 | CLN | Celsion Corp | MD | Health | ElcMd | Electromedical & Electrothera | Tardugno Michael H | MD | DO | P,CEO | P.a | 11 | 4.40 | 0 | 3 | 9 | 29 | D | | | | | | | | | | | | | | |
5/18/07 15:41 | 5/17/07 | CLN | Celsion Corp | MD | Health | ElcMd | Electromedical & Electrothera | Tardugno Michael H | MD | O | P,CEO | P | 11 | 4.81 | 0 | 2 | 31 | 10 | D | | | | | | | | | | | | | | |
2/27/07 16:04 | 2/23/07 | CLN | Celsion Corp | MD | Health | ElcMd | Electromedical & Electrothera | Tardugno Michael H | MD | O | P,CEO | P | 26 | 3.46 | 0 | 8 | New | 8 | D | | | | | | | | | | | | | | |